Apr 29, 2022 This Week in Cardiology Podcast

A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in cardiac amyloidosis, and a lipid guideline rebuttal are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare pr ...  Show more

Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a ...  Show more

The standard approach to losing weight, calorie restriction, tends to overlook critical biological elements like hunger hormones and the body’s innate intelligence. Meanwhile newer weight loss methods, like GLP-1 agonist drugs, can produce substantial weight loss, but have lastin ...  Show more

CardioNerds Dr. Rick Ferraro (CardioNerds Academy House Faculty and Cardiology Fellow at JHH), Dr. Gurleen Kaur (Director of the CardioNerds Internship and Internal Medicine resident at BWH), and Dr. Alli Bigeh (Cardiology Fellow at the Ohio State) as they discuss the growing obe ...  Show more

Twenty percent of obese people are in metabolically great health. Meanwhile sixty percent of supposedly ‘healthy’ weight people are metabolically unwell and at risk of a host of chronic diseases. With this in mind, do we need to change our thinking about what ‘being fat’ really m ...  Show more

Obesity is a physiological condition that can be managed with the right education and treatment. In today's episode, Dr. Louis J. Aronne, a leading expert in obesity research, sheds light on the science behind weight management and obesity treatment. Dr. Aronne dives into groundb ...  Show more